• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼曼-皮克C2型患者来源的诱导多能干细胞系AKOSi001-A的产生。

Generation of the Niemann-Pick type C2 patient-derived iPSC line AKOSi001-A.

作者信息

Völkner Christin, Peter Franziska, Liedtke Maik, Krohn Saskia, Lindner Iris, Murua Escobar Hugo, Cimmaruta Chiara, Lukas Jan, Hermann Andreas, Frech Moritz J

机构信息

Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, Gehlsheimer Straße 20, Rostock 18147, Germany.

Department of Medicine, Clinic III - Hematology, Oncology, Palliative Medicine, University Medical Center Rostock, Ernst-Heydemann-Straße 6, Rostock 18057, Germany.

出版信息

Stem Cell Res. 2019 Dec;41:101606. doi: 10.1016/j.scr.2019.101606. Epub 2019 Oct 15.

DOI:10.1016/j.scr.2019.101606
PMID:31669975
Abstract

Niemann-Pick disease Type C (NPC) is a rare progressive neurodegenerative disorder with an incidence of 1:120,000 caused by mutations in the NPC1 or NPC2 gene. Only 5% of NPC patients suffer from mutations of the NPC2 gene. Here we demonstrate the generation of a Niemann-Pick disease Type C2 (NPC2) patient-derived induced pluripotent stem cell line. This cell line is capable to differentiate into derivatives of the neuronal lineage, providing a valuable tool to study pathogenic mechanisms of NPC2.

摘要

C型尼曼-匹克病(NPC)是一种罕见的进行性神经退行性疾病,发病率为1:120,000,由NPC1或NPC2基因突变引起。只有5%的NPC患者患有NPC2基因突变。在此,我们展示了C2型尼曼-匹克病(NPC2)患者来源的诱导多能干细胞系的生成。该细胞系能够分化为神经谱系的衍生物,为研究NPC2的致病机制提供了一个有价值的工具。

相似文献

1
Generation of the Niemann-Pick type C2 patient-derived iPSC line AKOSi001-A.尼曼-皮克C2型患者来源的诱导多能干细胞系AKOSi001-A的产生。
Stem Cell Res. 2019 Dec;41:101606. doi: 10.1016/j.scr.2019.101606. Epub 2019 Oct 15.
2
Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the Mutations c.58G>T/c.140G>T.源自携带突变 c.58G>T/c.140G>T 的尼曼-匹克病 C2 型患者特异性 iPS 细胞的神经元分化细胞的病理生理体外特征。
Int J Mol Sci. 2021 Apr 13;22(8):4009. doi: 10.3390/ijms22084009.
3
Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease.早婴儿型尼曼-匹克病 C 型的临床和分子特征。
Int J Mol Sci. 2020 Jul 17;21(14):5059. doi: 10.3390/ijms21145059.
4
Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1.多能干细胞在尼曼-匹克 C1 型疾病建模和药物发现中的应用。
Int J Mol Sci. 2021 Jan 12;22(2):710. doi: 10.3390/ijms22020710.
5
Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.C型尼曼-匹克病:用于神经疾病建模和药物疗效评估的诱导多能干细胞衍生神经元细胞
J Biomol Screen. 2014 Sep;19(8):1164-73. doi: 10.1177/1087057114537378. Epub 2014 Jun 6.
6
Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling.通过调节WNT信号通路和钙信号挽救在1型尼曼-匹克病诱导多能干细胞衍生神经元中鉴定出的体外神经元表型。
Stem Cells Transl Med. 2015 Mar;4(3):230-8. doi: 10.5966/sctm.2014-0127. Epub 2015 Jan 30.
7
A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1.人诱导多能干细胞源性尼曼-匹克病 C1 型诱导性神经元模型。
BMC Biol. 2021 Oct 1;19(1):218. doi: 10.1186/s12915-021-01133-x.
8
Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.由于尼曼-匹克病 C1 型(NPC1)或 C2 型(NPC2)导致的动物模型中的肺部异常。
PLoS One. 2013 Jul 2;8(7):e67084. doi: 10.1371/journal.pone.0067084. Print 2013.
9
Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons.NPC1患者特异性诱导多能干细胞衍生神经元中糖鞘脂GM2的多样性和胆固醇积累
Brain Res. 2017 Feb 15;1657:52-61. doi: 10.1016/j.brainres.2016.11.031. Epub 2016 Dec 5.
10
FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.FTY720/芬戈莫德可增加尼曼-匹克C型突变成纤维细胞中NPC1和NPC2的表达,并减少胆固醇和鞘脂的积累。
FASEB J. 2017 Apr;31(4):1719-1730. doi: 10.1096/fj.201601041R. Epub 2017 Jan 12.

引用本文的文献

1
Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the Mutations c.58G>T/c.140G>T.源自携带突变 c.58G>T/c.140G>T 的尼曼-匹克病 C2 型患者特异性 iPS 细胞的神经元分化细胞的病理生理体外特征。
Int J Mol Sci. 2021 Apr 13;22(8):4009. doi: 10.3390/ijms22084009.
2
Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1.多能干细胞在尼曼-匹克 C1 型疾病建模和药物发现中的应用。
Int J Mol Sci. 2021 Jan 12;22(2):710. doi: 10.3390/ijms22020710.
3
Understanding and Treating Niemann-Pick Type C Disease: Models Matter.
理解和治疗尼曼-匹克 C 型疾病:模型很重要。
Int J Mol Sci. 2020 Nov 26;21(23):8979. doi: 10.3390/ijms21238979.